Madison Area Lyme Support Group

Update on Federal Lyme Funding For Fiscal Year 2022

November 3, 2021

https://www.lymedisease.org/lyme-funding-fy2022-cla/

Update on federal Lyme funding for Fiscal Year 2022

The Center for Lyme Action (CLA), a nonprofit based in Washington, D.C., lobbies on behalf of the Lyme community. Its goal is to expand federal funding for Lyme disease and other tick-borne illnesses. Here’s CLA’s latest message about what’s happening in Congress.

We’d like to update you on the Fiscal Year 2022 Congressional appropriations process for Lyme and tick-borne diseases.

As you may know, the House approved the following FY22 Lyme funding in late July:

$24 million for Centers for Disease Control and Prevention (CDC) Lyme & Tick-borne Disease (TBD) (+50% over FY21)
$7 million for Congressionally-Directed Medical Research Program (CDMRP) TBD Research Program (+$0% over FY21)
$5 million for LymeX Innovation Accelerator through a House Floor amendment with many of you weighing in with your support

We are now writing to let you know that the Senate Appropriations Committee last week — similar to last year– released “Explanatory Statements” for the Labor, Health and Human Services and Defense Appropriations with significant increases for Lyme disease:

+$20,000,000 increase for NIH NIAID (+50% over FY21) specifically Lyme disease and other tick-borne illnesses research.

+$2,000,000 for CDC (+12.5% over FY21) to support surveillance and prevention of Lyme disease and other high consequence tick-borne diseases in endemic areas as well as areas not yet considered endemic. (This includes funding for CDC’s vector-borne diseases program to expand the programs authorized under the Kay Hagan Tick Act.)

+$10,000,000 (+250% over FY21) for the Kay Hagan Tick Act, to address the increase in the incidence of vector-borne diseases and sustain the Regional Centers of Excellence program. (This includes state and local-level surveillance and research being conducted by partners.)

Additionally, both the House and Senate Appropriators released identical language calling for a plan to conquer Lyme and tick-borne diseases:

“The Committee looks forward to receiving the multi-year plan outlining innovation initiatives for conquering Lyme disease, which is due in December 2021.”

This is great news, but we’re not done yet with the FY22 appropriations work. The Senate and the House will go into negotiations soon. The only appropriations measures standing in the way are the $1.2 trillion infrastructure bill and the $3.5 trillion reconciliation bill with social and climate spending. And if the appropriations schedule is similar to last year, we may know the final result of the FY22 Appropriations for Lyme and tick-borne disease by the end of December.

We will continue to keep you posted on any additional developments as they come our way.

Best regards,

Jeff Crater, Bonnie Crater and Meredith Faucette
The Center for Lyme Action

P.S. For those of you interested in the details, below is the Explanatory Statement related to these Lyme Appropriations. This is the explanation from the Senate Appropriations Committee accompanying these increases for Lyme and TBD.

FY22 SENATE LABOR HHS APPROPRIATIONS

Centers for Disease Control and Prevention (CDC), Emerging and Zoonotic Infectious Diseases (NCEZID)

p. 82-83

Lyme Disease.—The Committee recommendation provides an increase of $2,000,000 in recognition of the importance of prevention and control of Lyme disease and related tick-borne diseases, and encourages CDC to support surveillance and prevention of Lyme disease and other high consequence tick-borne diseases in endemic areas as well as areas not yet considered endemic. The Committee includes funding for CDC’s vector-borne diseases program to expand the programs authorized under the Kay Hagan Tick Act (Public Law 116–94) to promote a public health approach to combat rising cases of tick-borne diseases. The Committee directs CDC to develop and implement methods to improve surveillance to more accurately report the disease burden, including through the development of real time data for reporting Lyme disease and other tick-borne diseases, as well as a process for estimating the prevalence of Post-Treatment Lyme Disease Syndrome. The Committee directs CDC to direct funding to improve early diagnosis of Lyme and related tick-borne diseases to prevent the development of late stage disease and more serious and long-term disability. The Committee encourages CDC to coordinate with NIH, the National Institute of Mental Health [NIMH], and the National Institute of Neurological Disorders and Stroke [NINDS] on publishing reports that assess diagnostic advancements, methods for prevention, the state of treatment, and links between tick-borne disease and psychiatric illnesses. The Committee urges CDC, in coordination with NIH, to include in their surveillance the long-term effects on patients suffering from post-treatment Lyme disease syndrome, or ‘‘chronic Lyme disease.’’ Additionally, given the impact of Lyme disease and the status of ongoing clinical trials, the committee requests a report within 180 days on CDC’s research to date and recommendations on actions needed to facilitate a successful Lyme disease vaccine rollout that will build confidence and encourage uptake should a vaccine be approved by the FDA.

p. 84
Vector-Borne Diseases [VBD].—The Committee includes an increase of $10,000,000 to address the increase in the incidence of VBD and sustain the Regional Centers of Excellence program, including State and local-level surveillance and research being conducted by partners. The Committee urges CDC to examine options to provide greater coverage in the Northwest region for VBD resources.

The National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)

p. 122

Lyme Disease and Related Tick-Borne Illnesses.—The Committee includes a $20,000,000 increase for Lyme Disease and other tick-borne illnesses research. The Committee encourages NIAID to use these funds to prioritize the support of meritorious research that informs a better understanding of Lyme disease pathogenesis and encourages the development of improved diagnostics and vaccines. The Committee directs NIH to leverage this understanding to develop new tools that can more effectively prevent, diagnose, and treat Lyme disease, including long-term effects, and other tick-borne diseases. The Committee encourages the promotion and development of potential vaccine candidates for Lyme disease and other tick-borne diseases. The Committee directs NIH to conduct research to better understand modes of transmission for Lyme and other tick-borne diseases, including vertical transmission. The Committee urges NIH to incentivize new investigators to enter the field of Lyme disease and other tick-borne disease research. The Committee directs NIH to coordinate with CDC on publishing reports that assess diagnostic advancements, methods for prevention, the state of treatment, and links between tick-borne disease and psychiatric illnesses.

Office of the Secretary, General Departmental Management

p. 219

LymeX Innovation Accelerator.—The Committee commends the Office of the Secretary and its Chief Technology Officer for the Lyme Innovation Initiative, launched November 2018, and the LymeX Innovation Accelerator announced in October 2020. LymeX is a $25,000,000 public-private partnership to accelerate innovation in prevention, diagnostics, and treatments for Lyme and other tickborne diseases. The Committee looks forward to receiving the multi-year plan outlining innovation initiatives for conquering Lyme disease, which is due in December 2021.

FY22 SENATE DEFENSE APPROPRIATIONS

Other Department of Defense Programs, Defense Health Program

p. 223

Peer-Reviewed Medical Research Program.—The Committee recommends $370,000,000 for the Peer-Reviewed Medical Research Program. The Committee directs the Secretary of Defense, in conjunction with the Service Surgeons General, to select medical research projects of clear scientific merit and direct relevance to military health. Research areas considered under this funding are restricted to: Alzheimer’s, arthritis, autism, burn pit exposure, cardiomyopathy, congenital heart disease, diabetes, Duchenne muscular dystrophy, dystonia, eating disorders, emerging viral diseases, endometriosis, epidermolysis bullosa, familial hypercholesterolemia, fibrous dysplasia, focal segmental glomerulosclerosis, food allergies, Fragile X, frontotemporal degeneration, Guillain-Barre syndrome, gulf war illness, hemorrhage control, hepatitis B, hydrocephalus, hypercholesterolemia, hypertension, inflammatory bowel diseases, interstitial cystitis, lupus, malaria, metals toxicology, mitochondrial disease, multiple sclerosis, myalgic encephalomyelitis/chronic fatigue syndrome, myeloma, myotonic dystrophy, nephrotic syndrome, neurofibromatosis, non-opioid therapy for pain management, nutrition optimization, Parkinson’s, pathogen-inactivated blood products, peripheral neuropathy, plant-based vaccines, platelet like cell production, polycystic kidney disease, pressure ulcers, pulmonary fibrosis, reconstructive transplantation, respiratory health, Rett syndrome, rheumatoid arthritis, sleep disorders and restriction, suicide prevention, sustained release drug delivery, tick-borne diseases [emphasis added], trauma, tuberous sclerosis complex, vision, vascular malformations, and women’s heart disease. The Committee emphasizes that the additional funding provided under the Peer-Reviewed Medical Research Program shall be devoted only to the purposes listed above.

p. 224-225

Chronic Pain Management Research.—The Committee recommends $15,000,000 for a chronic pain management research program to research opioid-alternative or non-addictive methods to treat and manage chronic pain. Chronic pain is defined as a pain that occurs on at least half the days for 6 months or more and which can be caused by issues, including but not limited to: combat- and training-related physical or mental stress and trauma, migraines and chronic headaches, traumatic brain injury, arthritis, muscular-skeletal conditions, neurological disease, tick and vector-borne disease, other insect-transmitted or tropical disease, and cancer. The funds provided in the chronic pain management research program shall be used to conduct research on the effects of using prescription opioids to manage chronic pain and for researching alternatives, namely non-opioid or non-addictive methods to treat and manage chronic pain, with a focus on issues related to military populations. The Committee encourages the Department to collaborate with non-military research institutions, such as the institutions of the National Institutes of Health Pain Consortium and the institutions represented in the Interagency Pain Research Coordinating Committee, to address the efforts outlined in the 2016 National Pain Strategy.

Category:

Activism, Lyme

Comments Off on Update on Federal Lyme Funding For Fiscal Year 2022

Raising Lyme Awareness One Car Magnet At a Time

https://www.lymedisease.org/lyme-awareness-car-magnets/

TOUCHED BY LYME: Raising awareness, one car magnet at a time

Dorothy Kupcha Leland

Oct. 28. 2021

A Pennsylvania teenager and her mom have come up with a great way to raise Lyme disease awareness in their community. They want to share the idea with everyone. And it’s so easy, you could even do it from bed.

Sarah P, who prefers not to give her last name, was bitten by a tick at age 13. She didn’t have a bull’s-eye rash, a fever, or joint pain—so her pediatrician said, “Nothing to worry about. You’re fine.” (Even though Pennsylvania is a hot bed for Lyme and other tick-borne diseases.)

Over the next several years, Sarah developed many seemingly unrelated symptoms that would come and go. Anxiety, headaches, leg pain. Followed by heart palpitations, GI issues, and memory problems. Eventually, POTS /dysautonomia symptoms set in, causing dizziness, nausea, and migraines.

No answers

Sarah saw a lot of specialists: a dysautonomia clinic, a neurologist, a G.I. doctor, an ENT, cardiologists, and physical therapists. Still, no answers and no improvement.

Then a neighbor told Sarah’s mom that her own daughter had been diagnosed with POTS as well. And it turned out that her POTS symptoms were caused by Lyme disease. Spurred on by their neighbor’s story, Sarah’s family sought out a Lyme-literate medical doctor. That LLMD diagnosed Sarah with Lyme and co-infections.

Throughout the arduous treatment process, Sarah and her mom wanted to warn other people about how one bite from an infected tick can ruin a person’s life. But how can you do anything when you are so sick and exhausted? How do you join a Lyme march in Washington or give a public speech when just getting out of bed is so difficult? The idea of Lyme advocacy seemed utterly impossible. And then Sarah had an idea.

Car magnets

While out on a drive with her mom, Sarah noticed a car sporting an awareness magnet for another disease. Hmmm, she thought. Could that work for Lyme? Would people even pay attention to it?

Then, she thought, what if you created a more specific magnet—such as NEURO Lyme Awareness, or CARDIO Lyme Awareness?

That might pique people’s curiosity. “NEURO Lyme? What the heck is THAT?” Such questions might lead them to pay more attention to the topic.

After a bit of research, the duo found that magnets can be quickly created via an online printing service or a local print shop. Soon, they turned their family van into a mobile bulletin board.

They’ve been so happy with the results, they want to share this idea with everybody.

Sarah and her mom have already done the design work. You are welcome to download the jpeg files from this blog—and create your own magnets.

Small magnets can be printed individually on rectangles or ovals, or several images can be placed on one large rectangular car magnet and cut apart easily with scissors.

Sarah’s mom negotiated with the online magnet printer StickyLife.com for a 15% discount if you use the following code: LYMEAWARE15. (Limited to one-time use per customer.)

Sarah, now 19, is in her second year of treatment and continues to fight for her health every day, Under the care of her LLMD, she says many of her symptoms have resolved. She reports that she can read again, enjoys writing her own music, and may start taking a couple of college courses.

Bravo, Sarah! I hope your health continues to improve and that these magnets will start popping up all over the country. I’ll be placing my order soon.

TOUCHED BY LYME is written by Dorothy Kupcha Leland, LymeDisease.org’s Vice-president and Director of Communications. She is co-author of When Your Child Has Lyme Disease: A Parent’s Survival Guide. Contact her at dleland@lymedisease.org.

Click on the download button below the design you would like. Right click the image and select “Save image as” to save to your computer. Go to an online magnet printing company (or a local print shop that makes magnets) and upload the file with your order. When you receive the magnets, you just stick them on your car. Easy-peasy!

Category:

Activism, Lyme

Comments Off on Raising Lyme Awareness One Car Magnet At a Time

“We See Clotting – NOT From Virus, but From Spike From ‘Vaccine’ Itself” & CDC Finally Weighs in On Natural Immunity

November 2, 2021

https://americasfrontlinedoctors.org/2/frontlinenews/we-see-clotting-not-from-virus-but-from-spike-from-vaccine-itself-aflds-medical-director-dr-ryan-cole/ Video Here (Approx. 1 Min)

‘We see clotting – not from virus, but from spike from vaccine itself’: AFLDS Medical Director Dr Ryan Cole

October 20, 2021

It doesn’t get much clearer than this.

These are not vaccines but clot shots.

__________________

https://www.washingtonpost.com/health/2021/11/01/what-works-better-vaccines-or-natural-immunity/

CDC finds immunity from vaccines is more consistent than from infection, but both last at least six months

Naturally acquired immunity is at the center of a political fight over President Biden’s vaccine mandates.

By Lena H. Sun and Joel Achenbach

Nov. 1, 2021

It’s a question that scientists have been trying to answer since the start of the pandemic, one that is central to the rancorous political debates over coronavirus vaccine policies: How much immunity does someone have after recovering from a coronavirus infection, and how does it compare with immunity provided by vaccination?

The Centers for Disease Control and Prevention has weighed in for the first time in a detailed science report released with little fanfare Friday evening. Reviewing scores of research studies and its own unpublished data, the agency found that both infection-induced and vaccine-induced immunity are durable for at least six months — but that vaccines are more consistent in their protection and offer a huge boost in antibodies for people previously infected. (See link for article)

_________________

**Comment**

Did you honestly believe the CDC would ever admit in 1,000 years that natural immunity is broader, more robust, and more effective than their dangerous, experimental, ineffective, unneeded lucrative shots (that aren’t vaccines), and that history and 15 studies clearly demonstrate? Even a former CDC director points out the complete bias against natural immunity by stating that the FDA, without presenting any data, issued a public safety statement:

“while SARS-CoV-2 antibody tests play an important role in identifying people who have been exposed to the SARS-CoV-2 virus and may have developed an adaptive immune response, antibody tests should not be used to determine immunity or protection against COVID-19.”

Huh?

So it’s fine to use inaccurate tests to inflate COVID cases and deaths, but it’s not fine to use them to prove immunity. It’s also fine to change testing perimeters for the “vaccinated,” to make it appear they are not getting infected with COVID, when “breakthough” infections are common due to vulnerability to variants. The“vaxxed” are being damaged from the injections, and even die from COVID. People are also dying due to the ineffective “Fauci protocol,”with some stating that “hospitals are modern day killing fields.” Despite Fauci are fed up with his filibustering.

Our corrupt public health ‘authorities’ happily spend your tax-dollars on grotesque Frankenstein, and dangerous research while continuing to make up science, bully dissenters, move goal-posts, change perimeters, and definitions, and lie with statistics without any oversight, to continue their narrative.

Remember, NIH developed the spike protein, which goes systemic in the body, crosses the blood, brain barrier, and has been determined to be a dangerous toxin. Also, remember our government is a vaccine manufacturer, completely in bed with Big Pharma. It is also worth repeating that the U.S. federal government partially owns an mRNA COVID-19 “vaccine” and soon before their rollout the U.S. federal government ensured COVID-19 mRNA vaccines would be legal by changing the definition of vaccines to include mRNA technology. This change occurred just weeks before the first “cases” broke out in the U.S. Mandates would have been much harder to impose without this change. Coincidence?

Epidemiologists estimate over 160 million people worldwide have recovered from COVID-19. Those who have recovered have an astonishingly low frequency of repeat infection, disease, or death. Immunity from prior infection protects – plain and simple. Regarding the injections; however, one expert states:

It’s worrisome that vaccination appears to deplete neutralizing Abs against the Spike protein gained by infection. It’s puzzling that vaccination appears also to deplete neutralizing Abs against the RBD (receptor-binding-domain) SARS-CoV-2 protein because the vaccines do not target that protein. – James Lyons Weiler

Further, governments are bound by Pfizer’s lucrative but secret indemnification agreement for which they must:

acknowledge efficacy and risks are unknown
put up sovereign assets and military bases
promise to not penalize Pfizer for deliver delays
exempt Pfizer from all civil liability
pay for everything (all damages, lawsuits, losses, penalties, fines, settlements, attorney’s fees, costs and expenses)
not apply domestic laws to the company
protect Pfizer against intellectual property theft, while they are free to use anyone else’s intellectual property
keep everything a secret for 10 years

It’s crystal clear why our government is censoring, maligning, and denying effective treatments for COVID and pushing the need for a “shot in every arm.” They have nothing to lose (except lives) and everything to gain. It’s also crystal clear why they downplay natural immunity, and the fact mortality from COVID is similar to the yearly flu. These inconvenient facts would cause “vaccine” hesitancy, and they can’t have that. Meanwhile, they completely ignore the vast devastation from lockdowns, fearmongering, and the “Fauci protocol.”

The following has billowed out (and continues to billow):

Pfizer Scientist caught on video: ‘Your antibodies are probably better than the vaccination’
Pfizer whistleblower has revealed these injections are bioweapons
Pfizer whistleblower has shown internal emails where they are attempting to hide their injections contain fetal cells
Pfizer scientist caught on video stating, “COVID Antibodies Pass Through Umbilical Cord to Fetus,” and also admits the Pfizer Covid vaccine “just doesn’t work” in some people

Vaccines are approved without proper safety studies, and nobody knows the effects of the cumulative effect of getting multiple vaccines. Many do not realize that Bill Gates, while pushing vaccines around the world that have caused hundreds of thousands of girls from India to be sterilized, doesn’t vaccinate his own children.

How many more whistleblowers will it take? When will people realize we are in the biggest propaganda scheme in history?

For more:

Category:

Activism, Treatment, vaccines, Viruses

Comments Off on “We See Clotting – NOT From Virus, but From Spike From ‘Vaccine’ Itself” & CDC Finally Weighs in On Natural Immunity

How Dr. Zelenko Bypassed the “HCQ Ban” to Beat COVID

https://plandemicseries.com/zstack/ Video Here (Approx. 8 Min)

Dr. Zelenko has successfully treated more than 1,450 COVID-19 patients with a 99% success rate using a cocktail of hydroxychloroquine, Zinc Sulfate and Azithromycin. Since the article in the link was written more than a year ago, the number of people he has treated is undoubtedly much higher. Also, please note the video within the link has been scrubbed from the internet. The ‘powers that be’ do not want you to know about successful, cheap, effective treatments. They want you to take their dangerous, lucrative jab that is linked to more adverse events and death than any other vaccine in history, but they profit from.

Dr. Zelenko also helped author a 52 page COVID “Vaccine” Death report.

The video in the top link has important information to know, including Dr. Zelenko’s COVID protocol that you can obtain over the counter. No prescription is needed. Protocols below were derived from the video. Dr. Zelenko was diagnosed with one of the rarest and most fatal cancers three years ago.

For the countless lives he’s saved, he was nominated for the Noble Peace Prize.

For COVID prevention:

zinc 25 mg 1/day
vitamin C 1000 mg 1/day
D3 500 IU 1/day
Quercitin 500 mg 2/day

For COVID treatment:

zinc 50 mg 1/day for 7 days
vitamin C 1000 mg 1/day for 7 days
D3 5000 IU 1/day for 7 days
Quercetin 500 mg 2/day for 7 days

**Dr. Zelenko has developed and is selling a product with all the ingredients included for those who want it**

________________

For more:

Public health ‘authorities’, bought out scientists and science journals, mainstream and social media, medical groups and Big Pharma all have blood on their hands and should be held accountable for their “fake news” regarding HCQ, ivermectin, and vitamins for treating COVID. These groups have rightly been called out for ‘fueling confusion and misinformation.”

You get the distinct impression they don’t want people to survive.

Similar to Lyme-land, real doctors are splitting away and forming their own alliances due to being hamstrung by regulators and hospitals literally killing people.

Current Government & Medical COVID policy = “get sicker,”and just take the jab already.

Category:

Activism, Supplements, Treatment, Viruses

Comments Off on How Dr. Zelenko Bypassed the “HCQ Ban” to Beat COVID

Lyme Disease Advocacy Organization Meets With FDA

Press_Release_-_October_2021

LYME DISEASE ADVOCACY ORGANIZATION MEETS WITH FDA

BOSTON, MA (October 25, 2021) — Nonprofit grassroots organization TruthCures met with Food & Drug Administration (FDA) officials last week to discuss issues related to notoriously inaccurate Lyme disease diagnostic tests. The group’s executive director, Laura Hovind, and associate Lahra Tillman were joined by Carl Tuttle, an appointee to New Hampshire Governor John Sununu’s Lyme Disease Study Commission, and their legal counsel, a former federal prosecutor. Kenneth Liegner, M.D., a longtime treating physician, published author and renowned Lyme disease expert participated remotely to demonstrate the deficiencies of the Lyme disease diagnostic method and the harm it does to patients.

At issue are 27 years worth of FDA-cleared Lyme disease diagnostic tests. Lyme disease is a bacterial illness caused by the bite of an infected tick. TruthCures claims the diagnostics are wholly inadequate because they are designed to detect only a small minority of cases predisposed to developing “Lyme arthritis,” a less-severe manifestation of the disease. They cited published literature and historical federal meeting documents that indicate the sicker Lyme disease cases are immunosuppressed and rarely test positive by the criteria that have been in place for nearly three decades.

“We are extremely pleased with the FDA’s response so far and are encouraged by how quickly they understood the problem and began thinking of solutions available to them within the regulatory framework,” said Tillman.

In a detailed presentation, the group explained how Lyme disease researchers’ financial interests in patents for the various bacterial components of diagnostic tests and vaccines have been prioritized over public health. They also shared results of an independent analysis by a diagnostics regulatory expert indicating there may have been irregularities with the process by which Lyme disease diagnostic tests were relabeled in the late 1990s. “We are very concerned that patients were left out of the equation when changes were made to the testing protocol,” said Hovind.

The group requested the FDA’s assistance in investigating the manipulated diagnostic protocol and its far-reaching effects, as well as coordinating with other agencies to evaluate related accepted standards they claim are inadequate. “As a public servant myself, I applaud the FDA investigators’ efforts to understand and act on information provided by concerned citizens,” noted Amy Kissinger, a member of TruthCures’ board of directors. “We are confident in their dedication to do the right thing in terms of the regulatory component of our claims.”

Added Hovind, “Our goal has always been to expose the truth and clear the way for accurate tests so the millions suffering this devastating disease can get the diagnosis and treatment they need. This development should give them hope that someone is striking at the root of the problem, and change is on the way.”

#

TruthCures is a registered 501(c)3 nonprofit organization dedicated to restoring a valid case definition for Lyme disease so all affected people can be accurately diagnosed and successfully treated. For more information, visit truthcures.org or email truth@truthcures.org.

Category:

Activism, Lyme, Testing

Comments Off on Lyme Disease Advocacy Organization Meets With FDA

Madison Area Lyme Support Group

Update on Federal Lyme Funding For Fiscal Year 2022